Inequalities in access to cancer treatment: an analysis of cross-regional patient mobility in Greece.
OBJECTIVE
The quest of specialized oncology services represents an inelastic need for cancer patients that often leads to traveling in order to receive adequate care. The present survey assesses patient geographic mobility to access services for the prevention and treatment of neoplasmatic diseases in Greece, a country where the National Health System is characterized by severe misdistribution of oncology-specific resources.


METHODS
Based on data from the National Statistical Service for 1999-2005 (last available), we estimated geographic mobility as the difference between oncology patients residing in a specific region and those receiving care in National Health System (NHS) facilities located in the region, for the ten administrative districts of Greece. Especially for Attica, we performed a sub-analysis according to cancer diagnosis.


RESULTS
The most significant mobility is towards Attica, where patients receiving care within the region outnumber the patients actually residing by 48.9% annually, on average. Positive flows are also observed towards Macedonia (8.4%) and Epirus (7.8%). Negative flows are recorded in all remaining regions, the highest noticed in Sterea (-76.2%), Ionian Islands (-63.3%), Aegean Islands (-45.2%), and Thessaly (-37.3%). The largest flow towards Attica is for cases of malignant neoplasms of the skin, uterus, male genital organs, and for Hodgkin's lymphomas.


CONCLUSIONS
Misallocation of oncology-specific resources creates "two-tier" cancer patients based on ability to pay for traveling/accommodation. The severity and the consequences of the disease necessitate a bold approach to resource allocation and the establishment of integrated patient support networks that ensure all cancer patients are offered equal opportunities to effective treatment.
Department of Health Economics, National School of Public Health, 196 Alexandras Av, Athens 11521, Greece. kathanasakis@esdy.edu.gr
Kostas
K
Athanasakis
Kyriakos
K
Souliotis
Elias-John
EJ
Kyriopoulos
Evangelia
E
Loukidou
Persefoni
P
Kritikou
John
J
Kyriopoulos
D003710:Demography; D006115:Greece; D006297:Health Services Accessibility / Q000706:statistics & numerical data*; D006301:Health Services Needs and Demand / Q000706:statistics & numerical data*; D006801:Humans; D008495:Medical Oncology / Q000458:organization & administration*; D009369:Neoplasms / Q000453:epidemiology / Q000628:therapy*; D011157:Population Dynamics / Q000706:statistics & numerical data*; D011159:Population Surveillance; D040841:Resource Allocation / Q000458:organization & administration*; D012959:Socioeconomic Factors; D014195:Travel / Q000191:economics
J Natl Cancer Inst. 2007 Jan 3;99(1):14-23
17202109
Qual Health Care. 1997 Jun;6(2):109-14
10173253
Eur J Oncol Nurs. 2007 Apr;11(2):141-50
16914376
Int J Nurs Pract. 2003 Jun;9(3):176-82
12801249
BMC Health Serv Res. 2007 Feb 15;7:21
17302970
Aust N Z J Public Health. 1998 Aug;22(5):525-7
9744202
JAMA. 2002 Jan 2;287(1):109
11754719
Eur J Cancer Care (Engl). 2000 Dec;9(4):197-203
11829366
Br J Cancer. 2006 Oct 9;95(7):944-9
16969351
Eur J Cancer Care (Engl). 2005 Mar;14(1):75-82
15698389
Am J Surg. 2008 Oct;196(4):572-4
18809065
Med Care. 2005 Jul;43(7):640-8
15970778
Am Surg. 2009 Jul;75(7):545-9; discussion 549-50
19655596
J Natl Cancer Inst. 2007 Jan 3;99(1):2-3
17202102
Health Policy. 2005 Oct;74(2):167-80
16153477
Cancer. 1999 Dec 1;86(11):2378-90
10590381
Fam Pract. 2002 Aug;19(4):369-74
12110557
Int J Health Geogr. 2004 Sep 29;3(1):21
15456514
Can Oncol Nurs J. 2005 Spring;15(2):107-19
15969333
Br J Cancer. 2003 Apr 7;88(7):1025-31
12671698
Hum Resour Health. 2006 May 27;4:12
16729892
J Natl Cancer Inst. 2008 Jun 18;100(12):888-97
18544740
Breast Cancer Res Treat. 2009 Sep;117(2):349-56
19051008
Cancer Pract. 1997 Nov-Dec;5(6):361-6
9397704